COVID-19 infection in a Down syndrome child

Area of Science:

• Pediatric Infectious Diseases
• Genetics and Rare Diseases
• Gastroenterology

Background:

• COVID-19 clinical presentation ranges from asymptomatic to critical illness, with children generally experiencing milder symptoms.
• Younger children and those with underlying conditions are at higher risk for severe COVID-19.
• Children with Down syndrome (DS) exhibit increased mortality rates from COVID-19 compared to the general pediatric population.

Observation:

• The SARS-CoV-2 virus utilizes Angiotensin-converting enzyme 2 (ACE2) receptors and transmembrane serine protease 2 (TMPRSS2) for cellular entry, particularly noted in the gastrointestinal tract.
• A case involving a Down syndrome infant with COVID-19 infection is presented.
• The infant exhibited significant gastrointestinal manifestations.

Findings:

• The COVID-19 infection in the DS infant led to severe hypernatremic dehydration.
• The dehydration and infection resulted in multiorgan dysfunction syndrome.
• This case underscores the vulnerability of DS infants to severe COVID-19 complications.

Implications:

• Early recognition and aggressive management of gastrointestinal symptoms are crucial for infants with Down syndrome infected with COVID-19.
• This case emphasizes the need for heightened vigilance and tailored care protocols for pediatric Down syndrome patients during the COVID-19 pandemic.
• Understanding the specific risks and presentations in vulnerable pediatric populations like those with DS is essential for improving clinical outcomes.